| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2014-03-26 | Kiobrina® (recombinant produced human bile-salt stimulated lipase) | treatment of preterm infants | 3 | Swedish Orphan Biovitrum - SOBI (Sweden) | |
| 2014-03-24 | MGN1703 (lefitolimod) | small cell lung cancer | 2-3 | Mologen (Germany) | Cancer - Oncology |
| 2014-03-24 | ISIS-HBVRx, formerly referred to a ISIS-GSK3 Rx | hepatitis B | 1 | Isis Pharmaceuticals (USA) GSK (UK) | Infectious diseases |
| 2014-03-22 | secukinumab (AIN457) | psoriasis |
3 | Novartis (Switzerland) | Autoimmune diseases - Dermatological diseases |
| 2014-03-21 | Liproca® Depot | localized prostate cancer | 2a | LIDDS (Sweden) | Cancer - Oncology |
| 2014-03-21 | cariprazine | major depressive disorder (MDD) | 2b | Forest Laboratories (USA) Gedeon Richter (Hungary) | CNS diseases - Mental diseases |
| 2014-03-20 | Milieu Interieur project - TruCulture technology | Institut Pasteur (France) Myriad RBM (USA) | Infectious diseases - Immunological diseases | ||
| 2014-03-19 | N8-GP (turoctocog alfa pegol) | hemophilia A |
3 | Novo Nordisk (Denmark) | Hematologic diseases - Genetic diseases - Rare diseases |
| 2014-03-19 | GFT505 | NASH (non-alcoholic steatohepatitis) | preclinical | Genfit (France) | Metabolic diseases - Liver diseases |
| 2014-03-18 | GLPG1790 | triple-negative breast cancer | preclinical | Galapagos (Belgium) | Cancer - Oncology |
| 2014-03-18 | P2B001 (combination of rasagiline and pramipexole) | Parkinson’s disease | 2b | Pharma Two B (Israel) | Neurodegenerative diseases |
| 2014-03-17 | bosentan | pulmonary arterial hypertension (PAH) |
4 | Actelion (Switzerland) | Rare diseases |
| 2014-03-17 | simeprevir (TMC435) | treatment-experienced adult patients with chronic hepatitis C virus (HCV) and compensated liver disease | 3 | Medivir (Sweden) | Infectious diseases |
| 2014-03-17 | drisapersen | Duchenne muscular dystrophy |
2 | Prosensa (The Netherlands) | Genetic diseases - Neuromuscular diseases - Rare diseases |
| 2014-03-17 | Dysport® (abobotulinumtoxin A) | Neurogenic Detrusor Overactivity (NDO) |
2a | Ipsen (France) | Neurological diseases - CNS diseases |
| 2014-03-17 | simeprevir (TMC435) | naïve adults with chronic genotype 1 hepatitis C virus (HCV) | 3 | Tibotec Pharmaceuticals-J&J (Ireland - USA) Medivir (Sweden) | Infectious diseases |
| 2014-03-16 | Kymouse™ technology | Kymab (UK) | Technology - Services | ||
| 2014-03-14 | Relvar®/Breo® Ellipta®(fluticasone furoate, vilanterol) | chronic obstructive pulmonary disease (COPD) | 3 | GSK (UK) Theravance (USA) | Respiratory diseases - Inflammatory diseases |
| 2014-03-14 | Anoro® Ellipta® | chronic obstructive pulmonary disease (COPD) | 3 | GSK (UK) Theravance (USA) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2014-03-13 | riociguat | pulmonary arterial hypertension (PAH) |
3b | Bayer Healthcare (Germany) | Rare diseases - Cardiovascular diseases |
